Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study.

Journal of the American Academy of Dermatology

Volumn 52, Issue 2, 2005, Pages 240-246

  Papp, Kim A ^a   Werfel, Thomas ^a   Fölster Holst, Regina ^a   Ortonne, Jean Paul ^a   Potter, Paul C ^a   de Prost, Yves ^a   Davidson, Miles J ^a   Barbier, Nathalie ^a   Goertz, Hans Peter ^a   Paul, Carle ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; PIMECROLIMUS; TACROLIMUS;

ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; INFANT; INTRADERMAL DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; OINTMENT; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; OINTMENTS; REMISSION INDUCTION; TACROLIMUS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 20444488914     PISSN: None     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2004.09.016     Document Type: Article

References (0)